Cross-source evidence timeline
Tesofensine research timeline
Follow 11 selected, directly cited source records from March 4, 2008 through September 3, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
Investigations Into the Metabolism and Elimination of Tesofensine in Human Urine.↗
PubMed lists PMID 42320973 in Drug testing and analysis as Journal Article, with publication-date metadata of 2026-06-19 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 19, 2026 · day precisionAdded to PeptideScanner November 16, 2026
Source year
2024
Clinical trials
ClinicalTrials.gov record NCT03149445↗
PeptideScanner retained ClinicalTrials.gov record NCT03149445 at 2026-11-16T17:29:46.323Z. Its registry update date was 2024-02-26, and PeptideScanner's reviewed identity mapping was tesofensine.↗
Added to PeptideScanner November 16, 2026
Source year
2021
Literature metadata
Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach.↗
PubMed lists PMID 17982477 in British journal of pharmacology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-11-05 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 5, 2007 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam.↗
PubMed lists PMID 19705923 in Clinical pharmacokinetics as Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009 (year precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2009 · year precisionAdded to PeptideScanner November 16, 2026
Source year
2020
Clinical trials
ClinicalTrials.gov record NCT02737891↗
PeptideScanner retained ClinicalTrials.gov record NCT02737891 at 2026-11-16T17:29:46.323Z. Its registry update date was 2020-05-14, and PeptideScanner's reviewed identity mapping was tesofensine.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT03286829↗
PeptideScanner retained ClinicalTrials.gov record NCT03286829 at 2026-11-16T17:29:46.323Z. Its registry update date was 2020-05-14, and PeptideScanner's reviewed identity mapping was tesofensine.↗
Added to PeptideScanner November 16, 2026
Source year
2018
Literature metadata
Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease.↗
PubMed lists PMID 17324246 in British journal of clinical pharmacology as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-02-23 (day precision). PeptideScanner associated the retained record with the identity slug tesofensine. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 23, 2007 · day precisionAdded to PeptideScanner November 16, 2026
Source year
2013
Clinical trials
ClinicalTrials.gov record NCT00394667↗
PeptideScanner retained ClinicalTrials.gov record NCT00394667 at 2026-11-16T17:29:46.323Z. Its registry update date was 2013-04-22, and PeptideScanner's reviewed identity mapping was tesofensine.↗
Added to PeptideScanner November 16, 2026
Source year
2011
Clinical trials
ClinicalTrials.gov record NCT00481104↗
PeptideScanner retained ClinicalTrials.gov record NCT00481104 at 2026-11-16T17:29:46.323Z. Its registry update date was 2011-07-04, and PeptideScanner's reviewed identity mapping was tesofensine.↗
Added to PeptideScanner November 16, 2026
Source year
2008
Clinical trials
ClinicalTrials.gov record NCT00428415↗
PeptideScanner retained ClinicalTrials.gov record NCT00428415 at 2026-11-16T17:29:46.323Z. Its registry update date was 2008-03-05, and PeptideScanner's reviewed identity mapping was tesofensine.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00006077↗
PeptideScanner retained ClinicalTrials.gov record NCT00006077 at 2026-11-16T17:29:46.323Z. Its registry update date was 2008-03-04, and PeptideScanner's reviewed identity mapping was tesofensine.↗
Added to PeptideScanner November 16, 2026